LYRA THERAPEUTICS INC (LYRAXXXX)
Institutional ownership reported to the SEC as of Q2 2025, across 21 quarters.
1
Reporting holders
$26
Reported value
0.0%
Held as options
-52
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| IFP Advisors, Inc | $26 | 300 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2025 | 1 | $26 | 300 | 1 | 0 | 0 | 0.0% |
| Q1 2025 | 53 | $3.2M | 25,554,008 | 6 | 11 | 18 | 0.4% |
| Q4 2024 | 49 | $5.5M | 26,788,157 | 6 | 18 | 9 | 0.1% |
| Q3 2024 | 55 | $8.3M | 32,259,526 | 15 | 11 | 12 | 0.1% |
| Q2 2024 | 47 | $8.8M | 31,604,308 | 10 | 14 | 13 | 1.0% |
| Q1 2024 | 73 | $285.3M | 45,562,501 | 19 | 27 | 13 | 0.7% |
| Q4 2023 | 58 | $244.2M | 46,367,294 | 17 | 20 | 3 | 0.5% |
| Q3 2023 | 42 | $125.5M | 31,859,298 | 10 | 14 | 3 | 0.8% |
| Q2 2023 | 36 | $139.1M | 33,626,008 | 10 | 11 | 4 | 0.7% |
| Q1 2023 | 27 | $37.9M | 18,809,653 | 1 | 3 | 4 | 0.0% |
| Q4 2022 | 33 | $59.3M | 18,883,259 | 6 | 8 | 5 | 0.1% |
| Q3 2022 | 35 | $96.0M | 19,156,774 | 8 | 7 | 9 | 0.1% |
| Q2 2022 | 33 | $108.9M | 19,268,543 | 13 | 9 | 5 | 0.0% |
| Q1 2022 | 24 | $20.2M | 5,023,218 | 0 | 6 | 8 | 0.0% |
| Q4 2021 | 32 | $36.5M | 8,367,875 | 6 | 7 | 9 | 0.0% |
| Q3 2021 | 34 | $60.8M | 6,667,024 | 3 | 6 | 14 | 0.0% |
| Q2 2021 | 39 | $81.9M | 10,202,555 | 10 | 4 | 17 | 0.0% |
| Q1 2021 | 49 | $87.6M | 7,560,152 | 9 | 13 | 13 | 0.0% |
| Q4 2020 | 43 | $98.0M | 8,595,912 | 8 | 22 | 3 | 0.0% |
| Q3 2020 | 39 | $85.7M | 7,656,403 | 4 | 12 | 14 | 0.0% |
| Q2 2020 | 43 | $79.8M | 7,037,339 | 43 | 0 | 0 | 0.0% |